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Summary 
The ~53 tumor suppressor is implicated here as a cru- 
cial barrier to unlimited cell proliferation. Its role In 
transformation of hematopoietic cells was studied by 
infecting fetal liver cells from wild-type or p53-‘- mice 
with oncogenic retroviruses. Transformed colonies 
arose with a raf and a myc-raf virus. Absence of ~53 
did not affect their frequency but proved crltlcal for 
their continued propagation. Colonies of p53-‘- cells 
bearing both myc and raf readily yielded continuous 
cell lines without apparent requirement for genetic al- 
teration. The lines, mainly of erythroid or myelomono- 
cytic origin, were diploid but highly tumorlgenic from 
their inception. These findings imply that ~53 losscon- 
tributes directly to immortalization and tumorlgen- 
esls, probably by abrogating an intrinsic senescence 
program. 
Introduction 
Although alteration of the ~53 tumor suppressor gene is 
the most frequent change in malignancy, the role played 
by loss of its function remains unclear (Donehower and 
Bradley, 1993). In the prevailing view, wild-type ~53 acts 
as a “guardian of the genome” (Lane, 1992); in cells that 
sustain DNA damage, the p53 protein level rises and in- 
duces either Gl arrest or apoptosis, allowing DNA repair 
or eliminating the cells, whereas cells lacking p53 function 
accumulate mutations (Livingstone et al., 1992; Yin et al., 
1992). In this model, ~53 loss promotes tumorigenesis 
simply by facilitating the acquisition of oncogenic muta- 
tions. It may, however, have additional and possibly more 
direct roles. Wild-type p53 can mediate cell death (Oren, 
1994), and ~53 ablation may spare nascent neoplastic 
clones from apoptosis (Lowe et al., 1994; Symonds et al., 
1994). 
The ~53 gene is also implicated in restriction of cell 
division potential. After a limited number of divisions (the 
Hayflick limit), normal cells subside into a senescent state 
(Hayflick and Moorhead, 1961), whereas tumor cells are 
thought to be immortal. Tellingly, introducing a mutant ~53 
gene facilitates establishment of permanent cell lines from 
primaryfibroblasts(Jenkinset al., 1984; Rovinski and Ben- 
chimol, 1988; Bond et al., 1994), and spontaneously im- 
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mortalized rodent fibroblasts often bear ~53 mutations 
(Harvey and Levine, 1991; Rittling and Denhardt, 1992). 
A plausible role in senescence for wild-type ~53 is that 
it induces expression of the gene for a 21 kDa protein, 
prominent in senescent cells, that inhibits cell cycle-regu- 
lating protein kinases required for Gl progression (Harper 
et al., 1993; El-Deiry et al., 1993; Noda et al., 1994). The 
notion that wild-type ~53 helps to impose the Hayflick limit 
is supported by evidence that cultured p53-‘- mouse em- 
bryo cells yield fibroblast lines more readily (Livingstone 
et al., 1992; Harvey et al., 1993; Tsukada et al., 1993), as 
do cells from patients with Li-Fraumeni syndrome (Bis- 
chaff et al., 1990). It remains controversial, however, 
whether ~53 inactivation suffices for immortalization and 
whether its loss acts directly (Bond et al., 1994; Tsukada 
et al., 1993; Lowe et al., 1994) or merely by allowing other 
mutations (Harvey et al., 1993). 
A deeper understanding of the role of ~53 loss requires 
clonal analysis in cell systems having well-defined differ- 
entiation. Evidence on its role in proliferation of nonfibro- 
blastic cells remains limited (Tsukada et al., 1993; Lotem 
and Sachs, 1993). We have focused on the well-character- 
ized transformation of erythroid precursors (reviewed by 
Metz, 1994). While normal erythroid progenitors require 
growth factors such as erythropoietin and soon differenti- 
ate into postmitotic erythrocytes, leukemogenic retrovi- 
ruses encoding a kinase oncoprotein such as v-ErbB or 
v-Raf allow the cells to grow without added factor, provid- 
ing a colony assay for transformation (Graf et al., 1981; 
Klinken et al., 1988). Viruses that also encode a nuclear 
oncoprotein, such as v-ErbA (Graf and Beug, 1983) or Myc 
(Blasi et al., 1985), further enhance self-renewal of the 
progenitors (Klinken et al., 1989). 
Although the initial transformation of avian and murine 
erythroid cells appears equivalent, their subsequent prolif- 
erative potential differs greatly. Transformed clones of 
chicken cells can undergo >40 population doublings (Graf 
and Beug, 1983), whereas murine clones cannot expand 
(Waneck and Rosenberg, 1981; Anderson et al., 1985; 
Klinken et al., 1988; Miller et al., 1990). This dichotomy 
may reflect the shorter endowed longevity of murine cells: 
8-20 doublings (Rohme, 1981; Harvey et al., 1993), com- 
pared with 30-50 for the chicken (Beug and Graf, 1977). 
Since a typical macroscopic colony of lo4 cells has ac- 
crued >13 divisions, the murine colonies may have 
reached their Hayflick limit. Breaching this barrier proba- 
bly requires mutation. The rare mouse erythroid lines aris- 
ing from mass cultures infected with the myc-raf or myc 
virus are clonal (Klinken et al., 1988; Cory et al., 1991), 
indicative of genetic alteration. 
If an intrinsic senescence program limits the prolifera- 
tion of erythroid cells, wild-type ~53 could be instrumental, 
because most mouse erythroid cell lines, which derive 
from erythroleukemias induced by the Friend retrovirus, 
bear ~53 alterations (Lane and Benchimol, 1990), as do 
all permanent avian erythroid lines (Ulrich et al., 1992). 
Hence, we tested whether the absence of ~53 would facili- 
tate generation of mouse hematopoietic cell lines by onco- 
genie retroviruses. We found that the absence of ~53 al- 
lowed virtually all clones induced by a myc-raf virus to 
expand indefinitely and readily provoke tumors. Thus, ab- 
lation of p53 together with activation of these oncogenes 
suffices for immortalization of hematopoietic cells. These 
findings establish that ~53 loss can contribute directly to 
tumorigenesis. Characterization of the lines also provided 
suggestive evidence of a checkpoint role for wild-type ~53 
late in the mitotic cycle. 
Results 
Absence of ~53 Does Not Influence Transformation 
or Erythroid Differentiation 
To determine whether transformation was affected by ~53 
status, we infected fetal liver cells from p53-‘- or wild-type 
mice, plated them in semisolid medium, and monitored 
them for colony formation (Klinken, 1988). The replication- 
incompetent viruses tested express the myc plus raf onco- 
genes, either gene alone, or simply a neo gene. Only the 
raf and the myc-raf viruses provoked colony formation 
(Table 1). Importantly, the absence of ~53 did not affect the 
number of colonies obtained in several such experiments, 
and it only enhanced colony size by - 50% (Table l), rep- 
resenting less than one extra cell division. Thus, transfor- 
mation per se was not influenced by the ~53 gene. 
Irrespective of ~53 status, all raf virus-transformed colo- 
nies and 85% of those generated with the myc-raf virus 
proved to be erythroid (see below). The v-raftransformants 
were dominated by mature cells; most cells were small 
(7-10 pm diameter), and an average of 60% stained with 
benzidine. By contrast, typical myc-raf erythroid colonies 
comprised blast-like cells of 1 O-15 urn, and only 30% ex- 
pressed hemoglobin. Hence, the erythroid colonies gener- 
ated by myc-raf are less mature than the fef trans- 
formants. Significantly, ~53 genotype did not affect the 
proportion of benzidine-positive cells obtained with either 
virus. Thus, erythroid differentiation does not seem to be 
influenced by ~53. 
Absence of ~53 Favors Indefinite Expansion 
Of my&f8f-TI’SItSfOmWd ClOneS 
Although colony development was unaffected by ~53 sta- 
tus, the absence of p53 greatly enhanced their subsequent 
Table 1. Capacity of Retroviruses to Transform Fetal Liver Cells 
Wild-Type Colonies ptX-‘- Colonies 
Virus Number. Cell ContenP Number’ Cell ContenP 
neo 0,o - 0,o - 
wc 0,o - 0,o - 
raf 11,ll 1.2 x 104 13,13 1.6 x 10’ 
myc-faf 40, 50 2.6 x 10’ 50,33 4.1 x lo” 
a Colonies per IO’ fetal liver ceils (duplicates). 
b Mean cell number per colony, determined from 20 successive col- 
onies 
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Figure 1. Enhanced Expandability of Individual Virus-Induced Colo- 
nies Lacking p53 
For expansion, primary colonies in semisolid medium were dispersed 
and cultured individually in liquid medium. A colony was scored as 
expanded when its progeny exceeded lOcells. The numbersof tested 
colonies were 179 p53- myc-raf, 151 wild-type (wt) myc-ref, 107 
~53~. raf, and 103 wild-type rat. 
expansion in liquid culture (Figure 1). While not one of 
103 wild-type raf colonies proliferated significantly, 18% of 
the p53-I- rafclones expanded beyond 10scells. Similarly, 
whereas <lo% of wild-type myc-raf colonies could be 
propagated, virtually every p53-‘- myc-faf clone (98%) 
whether erythroid or nonerythroid, readily expanded. Hence, 
the absence of ~53 markedly augmented clonal longevity. 
After a few days in liquid culture, the ~53’ myc-raf 
clones appeared distinct from those of other genotypes. 
Microscopically, their cultures were uniformly healthy, 
whereas the others comprised dying populations, from 
which rare subclones sometimes emerged (data not 
shown). This dichotomy in growth pattern was also evident 
from clonal analysis of viability (Figure 2A) and the kinetics 
of expansion (Figures 28 and 2C). The p53-/- myc-raf 
clones, whether erythroid or nonerythroid, expanded con- 
tinuously without a crisis (Figure 2B), a delay occurring 
only in the few dominated by mature (smalt, hemoglobin- 
positive) cells. The typical clones doubled every 10 hr (Fig- 
ure 2C). By contrast, with every other genotype, viability 
began to fall after only 3 days; all wild-type raf clones were 
extinguished within 1 week, and most wild-type myc-raf 
and p53-‘- raf cultures within 3 weeks (Figure 2A). The 
sporadic expansion of the persisting cultures, typically 
after 10-15 days (Figure 2B), clearly relied on selective 
growth of rare cells, indicative of genetic atteration. Even 
during expansion, extensive cell death (200/b-70%) some- 
times persisted for several weeks, and growth rates gradu- 
ally increased (Figure 2C), perhaps reflecting successive 
mutations. Clonal survival was not notably enhanced by 
erythroid growth factors such as erythropoietin, stem cell 
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Figure 2. Viability and Expansion of Erythroid Clones over Time 
Between 40 and 50 erythroid colonies of each genotype were seeded 
individually in 96well plates (day 0). Shown are the proportion of viable 
clones (A), the cumulative percentage of expanded clones (6). and 
the kinetics of proliferation for representative individual clones (C). A 
clone was scored as viable as long as any live cells could be detected 
microscopically and as expanded when the well was confluent, requir- 
ing transfer to a 24-well dish; this corresponded lo -2 x 105 to 3 x 
105 cells. wt, wild tyfie. 
factor, or interleukin-3. Thus, as observed by Klinken et 
al. (1988) clonal longevity did not appear to be dependent 
on these growth factors. 
To determine whether expanded colonies could yield 
permanent lines, we monitored representative clones on 
prolonged culture. We cultivated 15 p53-‘- myc-raf clones 
(ten erythroid and five nonerythroid), eight p53-‘- raf ery- 
throid clones, and three wild-type myc-faf nonerythroid 
clones from 2 months to >6 months, representing from 
100 to >300 doublings. Not a single clone senesced or was 
lost. Thus, cell lines arise consistently from expandable 
colonies. 
High Proportion of Immortal Cells in 
p53+ myc-raf Colonies 
If the absence of p53 directly eliminated a barrier to indefi- 
nite proliferation rather than merely allowing “immortaliz- 
p53: -I- wt 
mydra f 
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raf 
Figure 3. Higher Clonogenicity of ~53’ myc-raf Colonies 
Primary erythroid colonies of the indicated genotypes were seeded 
individually in liquid culture. While viability still remained high in wild- 
type (wt) myc-ref and p53’- raf colonies, the cells were replated 3 days 
later in methylcellulose. The plating efffciency (number of secondary 
colonies per 100 cells seeded) was determined 6 days later. Each 
symbol shows the plating efficiency of an individual primary colony, 
and the type of symbol indicates either the average size of secondary 
colonies or the absence of growth. Clusters were defined as aggre- 
gates containing up to 500 cells. Symbols below the broken line repre- 
sent replating efficiencies of <O.l%. 
ing” mutations to develop, a high proportion of cells in 
each primary colony should be immortal. We tested this 
hypothesis by secondary colony assays (Figure 3). The 
p53-‘- myc-ref colonies proved to be highly clonogenic. 
All of 22 erythroid clones that proliferated well in parallel 
liquid cultures replated with efficiencies from 5% to S&It% 
(mean, 29%) values as high as with well-established lines. 
Moreover, all of 25 secondary colonies tested yielded large 
tertiary colonies at high efficiency (>lO%), while another 
50 all expanded rapidly in liquid culture. Nonerythroid 
p53-‘- myc-raf colonies behaved similarly (data not 
shown). Thus, a substantial proportion of cells in each 
primary p53-‘- myc-raf colony can proliferate indefinitely, 
favoring a direct role for ~53 loss in immortalization (see 
Discussion). 
By contrast, erythroid colonies of the other three geno- 
types exhibited minimal clonogenicity (Figure 3). Nearly 
all resulting colonies contained <200 cells, and even the 
rare secondary colonies possessing up to 5 x 103 cells 
did not expand in liquid culture or initiate tertiary colonies. 
Hence, the transformed clones of these genotypes ap 
peared to have exhausted their growth potential. 
All these data suggest that prolonged expansion of wild- 
type myc-ref and p53-I- raf colonies requires additional 
genetic changes, while activated myc and raf oncogenes 
in a p53+ context are sufficient for immortalization. 
Transformed Cell Lines Repreeent Different 
Hematopoletlc Lineages and Ftemain 
Able to Differentiate 
Analysis of representative cell lines by tests for globin ex- 
pression (Northern blots and benzidine staining) and by 
flow cytometric analysis for lineage-specific surface anti- 
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Figure 4. Karyotypic Profiles of Erythroid ~53.‘~ myc-ref Cell Lines 
Shown are a cell line after 30 population doublings (A), a diploid (B) 
and a near diploid (C)tumor cell line established from leukemic animals 
that had been injected with 1V of the diploid cells shown in (A), and 
another cell line at late passage (>150 population doublings) (D). 
gens confirmed that erythroid lines predominated. Most 
of these contained some ceils bearing the erythroid marker 
Ter-119, while none expressed myelomonocytic markers 
(F4/80, Mac-l, or Gr-1). Interestingly, the receptor for stem 
cell factor, c-Kit, was expressed in most p53-‘- raf lines, 
but in only one of 13 myc-raf erythroid lines generated 
from either p!W- or wild-type cells. This finding may indi- 
cate that the raf and myc-raf viruses preferentially trans- 
form different erythroid progenitors or that up-regulation 
of c-Kit favors establishment of the raf transformants. 
The erythroid lines remained able to differentiate. Eryth- 
ropoietin increased the proportion of benzidine-positive 
cells by 2- to 40-fold in all of 24 erythroid p53-‘- myc-raf 
lines and all of seven p53-‘- raf lines tested. Hence, the 
absence of p53 does not interfere with erythropoietin- 
induced differentiation. 
The majority of nonerythroid myc-raf transformants 
were clearly myelomonocytic. They expressed F4/80 and 
Mac-l, and some displayed Gr-1, Thy-l (which is often 
found on primitive myelomonocytic cells), or both. Several 
other lines, however, lacked all markers tested and proba- 
bly represent hematopoietic progenitors. of these lines, 
two differentiated spontaneously into macrophages and 
must represent myeloid precursors. 
Early Passage p53-I- myc-raf Cells 
Are Tumorigenic 
Do genetic changes that allow immortalization suffice for 
tumorigenesis? Leukemia developed within a few weeks 
in mice injected intravenously with seven established cell 
lines. However, because mutation may accompany estab- 
lishment of lines, transplantation tests were performed on 
freshly isolated p53-‘- myc-raf colonies as soon as suffi- 
cient cells accumulated. After only 6-10 days in liquid cul- 
ture, four erythroid clones were injected intravenously. By 
3-8 weeks later, every recipient had developed erythro- 
leukemia. Ten other new clones (five erythroid and five 
nonerythroid) yielded tumors within 3 weeks. The tumors 
clearly derived from the transplanted cells, because rees- 
tablished cell lines yielded polymerase chain reaction 
products specific for the p53-‘- mice. Hence, activation of 
the myc and raf oncogenes plus inactivation of p53 may 
be sufficient to render mouse hematopoietic cells fully tu- 
morigenic. 
~53~‘~ Cell Lines Can Remain Diploid, Even after 
Growth as a Tumor 
Since fibroblasts lacking p53 display karyotypic instability 
(Harveyet al., 1993; Tsukada et al., 1993) we enumerated 
the chromosomes in our p53-I- erythroid cell lines. Signifi- 
cantly, even after 3-4 weeks in liquid culture (30-40 popu- 
lation doublings), all ten p53-‘- myc-raf lines analyzed re- 
tained a diploid karyotype; i.e., the vast majority of cells 
contained 40 chromosomes (e.g., Figure 4A) and exhibited 
no marker chromosome. Moreover, of eight raf lines exam- 
ined, five were diploid and three aneuploid. Thus, aneu- 
ploidy is not necessary for immortalization. 
To investigate karyotypic stability during tumorigenesis, 
we transplanted diploid p53-‘- myc-raf cell lines into mice 
and analyzed the karyotype of cell lines grown from the 
resulting tumors. Of eight lines, three remained diploid 
(e.g., Figure 4B), and four of the remaining five were near 
diploid; i.e., a substantial proportion of cells retained 40 
chromosomes (Figure 4C). Only one of the eight tumor 
lines was aneuploid, with 39 chromosomes most preva- 
lent. None of these lines displayed highly variable num- 
bers of chromosomes in individual cells, although instabil- 
ity was occasionally observed in lines cultured for >2 
months, representing >150 doublings (Figure 4D). Thus, 
~53 loss does not directly impose karyotypic instability. 
Multinucleate Cells in Lines Lacking ~53 
Many of the p53-‘- lines contained a small subpopulation 
of abnormally large multinucleate cells, with a diameter 
of 940 pm (Figure 5A). Their presence correlated with 
the metaphase spreads exhibiting multiples of the normal 
chromosome set (Figure 5B), occasionally reaching >lOOO 
chromosomes. The giant cells were not observed in freshly 
isolated myc-raf clones from wild-type cells but were 
found in most, if not all, erythroid p53-‘- myc-raf clones, 
even at early passage; in some marker-negative p53-‘- 
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Figure 5. Multinucleate Cells in ~53~‘. myc-raf and ~53.‘~ raf Cell Lines 
(A) Cytospin preparation of an early passage ~53.‘~ myc-raf cell line stained with May-GrOnwald-Giemsa (magnification, 700 x ). (B) Giemsa-stained 
metaphase chromosomes of two cells from an early passage ~53~‘~ myc-raf line (magnification, 300x). (C) Benzidine staining of a postcrisis 
~53~‘~ raf cell line before (left) and after (right) induction for 72 hr with 4 U/ml human recombinant erylhropoietin (magnification, 150 x). 
myc-raf lines; and in many postcrisis p!Q-‘- raf clones. 
Hence, their presence appeared to correlate with the ab- 
sence of the p53 gene. 
Although giant cells usually comprised <l% of a culture, 
erythropoietin-treated clones and cultures recently initi- 
ated from cryopreserved clones contained many more, in 
extreme cases up to 50% of the cells (Figure 5C). A poten- 
tial relationship to megakaryocytes, a polyploid cell type 
sometimes found in predominantly erythroid lines, was 
ruled out by the consistent failure of the giant cells to stain 
for acetylcholinesterase. Instead, most of those in ery- 
throid lines stained strongly with benzidine (Figure 5C), 
identifying them as erythroid. These findings may indicate 
that loss of ~53 impairs the control of cytokinesis (see 
below). 
Discussion 
Breaking the Barriers to Indefinite Proliferation 
The most striking finding of this study was that the absence 
of ~53 allowed the efficient immortalization of hematopoi- 
etic cells. Virtually every colony of ~53~‘~ cells induced 
by infection with a myc-raf retrovirus readily expanded in 
liquid culture (Figures 1 and 2). Viability remained uni- 
formly high, and a substantial proportion of cells in each 
primary colony could propagate the line (Figure 3). Clones 
appeared able to proliferate indefinitely, doubling every 
10 hr, without evidence of crisis or a senescent phase. 
We conclude that the myc-raf combination renders ~53~‘~ 
cells immortal. 
By contrast, derivation of lines from wild-type cells car- 
rying myc and raf or of p53-‘- clones containing only the 
raf oncogene almost certainly required mutation. Exten- 
sive cell death preceded the sporadic expansion of clones, 
and high clonogenicity appeared only after establishment. 
From the proportion of these clones that did expand, we 
infer that only 1 in 105 transformed cells could produce a 
line. Thus, loss of ~53 greatly facilitates immortalization 
but does not suffice. 
The need for several genetic changes to immortalize 
cells undoubtedly reflects the multiple barriers that nor- 
mally constrain indefinite proliferation. As illustrated in Fig- 
ure 6, three major impediments are dependence on growth 
factors for both proliferation and survival, the inbuilt pro- 
gram of terminal differentiation characteristic of each cell 
lineage, and, perhaps the ultimate defense, the Hayflick 
limit thought to hold for most cells within an organism. It 
seems instructive to consider in turn how the oncogenes 
and ablation of ~53 help to overcome these barriers. 
Because Raf and Myc lie on separate signal transduc- 
tion pathways emanating from many growth factor recep- 
tors, both are likely to contribute to relief of growth factor 
requirements. For erythroid progenitors, Raf must allow 
limited autonomous growth, since erythroid colonies arise 
with v-raf alone (Klinken, 1966; see Table 1). Because 
their liquid cultures soon perished, however, v-Raf alone 
probably provokes (or allows) normal terminal erythroid 
maturation or gives an unbalanced mitogenic signal that 
triggers apoptosis. The oncogenic synergy between Myc 
and Raf (Blasi et al., 1985; Principato et al., 1990), like that 
of Myc and Ras, may reflect a need for two complementary 
mitogenic signals to achieve autonomy. Myc can also im- 
pede maturation, including that of erythroid cells (Coppola 
and Cole, 1986), perhaps by hastening their passage 
through a Gl state from which differentiation normally en- 
sues. That Myc increased self-renewal of the progenitor 
cells at the expense of terminal differentiation is supported 
by the less mature phenotype of the myc-raf clones than 
the raf-only ones, regardless of the presence of ~53, and 
by the much higher proportion of clonogenic cells in the 
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Figure 6. Proposed Roles of Raf, Myc, and ~53 Loss in Overcoming 
the Barriers to Indefinite Proliferation 
In this model, the concerted action of Myc and Raf allows cells to 
proliferate in the absence of growth factors. Myc also reduces terminal 
differentiation by increasing the proportion of self-renewing divisions. 
Loss of ~53 is proposed to abrogate enforcement of a separate Intrinsic 
limit on the number of permissible cell divisions (the Hayflick limit). 
myc-raf transformants (Figure 3). Thus, Myc plus Raf may 
render the cells autonomous and hinder their normal termi- 
nal differentiation, circumventing the first two barriers 
(Figure 6). 
What role did the absence of ~53 play? Did it simply 
prevent the exit from the cell cycle that attends terminal 
erythroid differentiation? That might hold for the faf trans- 
formants but seems very unlikely for the myc-raf ones 
because the typical etythroid and many nonerythroid 
clones were immature. Did it merely prevent cell death 
provoked by deficient culture conditions? Such effects 
cannot be completely discounted, but infected primary 
p53-‘- cells did not yield more colonies or substantially 
larger ones (Table l), and liquid cultures supplemented 
with factors that favor survival of erythroid cells did not 
allow wild-type clones to expand. Did absence of ~53 spare 
the cells from some tendency to apoptosis engendered 
by Myc plus Raf? Reduced apoptosis has been proposed 
to explain the increased frequency with which ~53” fibro- 
blasts are immortalized by the adenovirus El A gene (Lowe 
et al., 1994). On this hypothesis, however, the absence 
of ~53 should have enhanced the initial production of colo- 
nies by the myc-raf virus. No such effect was found 
(Table 1). 
~53 as an Enforcer of Senescence 
Because enhanced clonal longevity was the major conse- 
quence of p53 loss observed here, we suggest that ~53 
ablation opensa third barrier, distinct from lineage-specific 
terminal differentiation. This may represent an intrinsic 
senescence program that ensures the eventual loss of 
proliferative capacity by normal somatic cells (Figure 6). 
A general role for wild-type ~53 in enforcing a Hayflick 
limit on any given cell type would explain why p53-‘- cells of 
hematopoietic and fibroblastic lineages are both rendered 
susceptible to immortalization, even though wild-type ~53 
can inducedifferent fates, apoptosis in hematopoieticcells 
and growth arrest in fibroblasts. It would also provide a 
clear parallel with avian studies, in which it has been 
shown that the rare clones that proliferate indefinitely have 
all suffered ~53 lesions (Ulrich et al., 1992). In this model, 
growth of our p53-‘- raf clones is constrained by normal 
terminal differentiation, while wild-type myc-raf clones en- 
counter the Hayflick limit. However, other models for re- 
stricted growth, such as a requirement for unidentified 
growth factors, cannot as yet be ruled out. 
Does the absence of ~53 function directly augment 
clonal longevity or merely allow outgrowth of cells sus- 
taining mutation, e.g., in a senescence gene? Our results 
strongly favor a direct role. The high replating efficiency 
in nearly every colony of p53+ myc-raf cells (Figure 3) 
would demand mutation within the first few cell divisions, 
i.e., a rate vastly exceeding known mutation rates (Holli- 
day, 1969). A direct role is also favored by the diploid 
karyotype retained by the p53-‘- myc-raf lines for >30 pop- 
ulation doublings (Figure 4A). Thus, wild-type ~53 may be 
an important component of the trigger for senescence. In 
fibroblasts, ~53 is likely to act via induction of the p21 
inhibitor of cyclindependent kinases operative in the Gl 
phase (Noda et al., 1994; Harper et al., 1993; El-Deiry et 
al., 1993) but the mechanism by which it induces apop- 
tosis in hematopoietic cells is less well understood (Oren, 
1994). 
lmmortallzation as a Step Toward Tumorigenesls 
Our results suggest that overcoming senescence may 
contribute substantially to tumor development. The im- 
mortal clones of p53+ myc-raf cells appeared to be tumor- 
igenic from their inception. Consistent with the possibility 
that these three genetic alterations render an immature 
hematopoietic cell fully malignant, some cell lines recov- 
ered from the tumors remained diploid (Figure 58). Since 
not all tumors arose synchronously, however, and a few 
had an altered karyotype, growth in the animal may some- 
times select a more malignant subclone. 
A plausible model for cellular senescence is that cell 
divisions are “counted” by gradual attrition of telomeres 
of chromosomes (de Lange, 1994) until a threshold length 
triggers p53-induced arrest or apoptosis. At least for hu- 
man cells, extensive propagation beyond this barrier may 
require reactivation of telomerase activity. The presence 
of telomerase in >90% of primary human tumors and virtu- 
ally all cell lines, but not in normal human somatic tissues, 
underlines the importance for tumorigenesis of overcom- 
ing senescence (Kim et al., 1994). Hence, bypassing se- 
nescence may be the major contribution of ~53 alteration 
to tumor development. It probably also contributes by 
sanctioning persistence of cells sustaining DNA damage 
(see Introduction), allowing proliferation under suboptimal 
conditions (Harvey et al., 1993) and sparing from apop- 
tosis cells bearing oncogenic changes (Lowe et al., 1994; 
Symonds et al., 1994). The multiplicity of checkpoints un- 
der surveillance by ~53 may account for its frequent alter- 
ation at either early or late stages of tumorigenesis. 
A Potential Mitotic Checkpoint Role for p53 
A distinctive checkpoint role for wild-type ~53 may account 
for our detection of multinucleate cells in p53-‘- lines (Fig- 
ure 5). Possible precedents are that some p53-‘- animals 
develop giant multinucleated spermatocytes (Rotter et al., 
1993) that many early-passage p53-‘- fibroblasts are hy- 
perdiploid (Harvey et al., 1993) and that the pancreas 
of ~53~‘~ mice contains some cells with a tetraploid DNA 
content (Cross et al., 1995). Hence, in addition to its Gl 
checkpoint role(s) (Donehower and Bradley, 1993) wild- 
type ~53 may help to monitor mitosis and meiosis, perhaps 
forming part of a checkpoint designed to stop cells from 
reentering the cell cycle before completing cytokinesis or 
to kill those that do. The system monitored might be the 
mitotic spindle (Cross et al., 1995) or completion of cytoki- 
nesis. 
Facile Generation of Differentiating Cell Lines 
Evidence that overexpression of wild-type ~53 can pro- 
voke terminal differentiation has suggested a role in con- 
trol of maturation (Prokocimer and Rotter, 1994). In our 
work, however, ~53 status had no effect on erythroid differ- 
entiation, nor was any observed in avian cells (Ulrich et al., 
1992). In view of recent evidence (reviewed by D’Andrea, 
1994) that terminal erythropoiesis proceeds via extension 
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of the Gl phase, transient Gl delay triggered by ~53 over- 
expression may force maturation, even though the normal 
pathway usually bypasses ~53. 
Our observation that the absence of ~53 does not per- 
turb cellular phenotype or differentiation capacity makes 
p53-‘- mice a particularly attractive source for novel cell 
lines. With p53-‘- fetal liver cells, the myc-raf virus readily 
yielded lines of erythroid and myelomonocytic cells as well 
as a putative myeloid progenitor, and lymphoid cells al- 
most certainly would also be obtained with an appropriate 
culture medium. Hence, it should be feasible to derive 
factor-independent cell lines representative of most hema- 
topoietic lineages and maturation stages, perhaps includ- 
ing rare cell types such as the stem cell. Diverse nonhema- 
topoietic cells should also be accessible. 
Experlmental Procedures 
Retroviruses, Infection of Fetal Liver Cells, arid Colony Assays 
All viruses were produced in helper-free form using Y2 packaging cell 
lines provided by Dr. S. Gory. The myc-raf virus was J2 (Rapp et al., 
1963) the raf virus (encoding v-raf) was 3611 murine sarcoma virus 
(Rapp et al., 1963) the myc virus (carrying the mouse c-myc gene) 
was MPZen(myc) (Gory et al., 1991) and the neo control virus was 
ZipNeo (Cepko et al., 1964). 
Fetal livers were pooled from day 12 or day 13 wild-type or p53*/‘ 
embryos (Livingstone et al., 1992). The ~53.‘. embryos, identified by 
PCR analysis (Livingstone et al., lQQ2), came from matings between 
~53~‘. parents containing on average 90% C57BL/6,7% SJL, and 3% 
129 alleles. (Mice with a simpler genotype were not available because 
of a low yield of p5b’- females from matings of >QQ% C57BU6 mice.) 
The wild-type embryos were progeny of (C57BU6 x SJL)Fl females 
and C57BU6 males. 
For retroviral infection, typically 7.5 x IO fetal liver cells were culti- 
vated on a layer of irradiated (26 Gy) virus-producing Y2 cells in Dul- 
becco’s modified Eagle’s medium (DMEM) supplemented with 20% 
fetal calf serum and 1000 U/ml interleukin-3, supplied as conditioned 
medium from the cell line X63Ag6-653mlL-3 (Karasuyama and Mel- 
chers, 1966). After 2 days, the nonadherent ceils were replated in a 
new dish for 2 hr to deplete any contaminating adherent cells and 
then seeded at several densities (2 x 16 to 5 x IO’ cells per 36 mm 
dish) in 1 ml of semisolid Iscove’s modified Dulbecco’s medium (IMDM) 
containing 1.44% methylcellulose (Fluka), 20% fetal calf serum, and 
0.1 U/ml human recombinant erythropoietin. IMDM plus 20% fetal calf 
serum was used routinely, because pilot experiments showed it to be 
superior to the more commonly used DMEM plus 10% fetal calf serum 
for maintenance of etythroid clones. 
Large macroscopic’colonies were scored and picked on day 6 or 
7. To determine their average cell content, 20 successive colonies 
were pooled and the cells counted in a hemocytometer. Secondary 
colony assays used the same conditions as the primary assays; 5 x 
102 to 10’ cells were seeded in 1 ml of semisolid medium in a 36 mm 
dish. Plating efficiency was not affected by the number of plated cells. 
Expansion in Liquid Culture, Cytochemlcal Staining, Response 
to Erythropoietin, and Flow Cytometry 
Colonies were transferred individually into flat-bottomed 96well plates 
containing 100 PI of medium per well. (To avoid differentiation effects, 
we usually omitted erythropoietin.) Cultures were kept at 5 x 105 to 
2 x IO6 cells per milliliter by daily partial medium exchange. 
Cytocentrifuged cells were stained with modified Wright’s stain (Diff- 
Quick, Lab-Aids) or with May-Griinwald-Giemsa stain (Metcalf, 1964) 
or for acetylcholinesterase (Karnovsky and Roots, 1964). Hemoglobin 
was detected in cell suspensions with benzidine (Cooper et al., 1974). 
To assess responsiveness to erythropoietin, we grew subcultures for 
3 days in the presence or absence of 4 U/ml human recombinant 
erythropoietin and determined the proportion of benzidine-positive 
cells. 
To detect surface antigens, cells were stained with monoclonal anti- 
bodies and analyzed by flow cytometry as described previously (Stras- 
ser et al., 1991). 
Transplantation, Tumor Dlagnosis, and Reestablishment 
of Cell Lines 
Cells were injected into female CBAlCaHnu mice (three per cell line) 
intravenously, subcutaneously, and intraperitoneally(lOcellsfor each 
route, i.e., 3 x lo8 cells/mouse) or only intravenously (IO8 cells/ 
mouse); nude mice were used because of the mixed genetic back- 
ground of the test cells (see above). Terminally il l animals were sacri- 
ficed and analyzed for gross pathology. Blood smears and histological 
sections of organs and tumors were examined. Cell lines could be 
readily established from all solid tumors and from hematopoietic tis- 
sues of animals with erythroleukemia. 
Chromosome Enumeration 
Cells cultured for 2-2.5 hr in 1 pM colchicine were allowed to swell 
for 10 min in 0.56% (w/v) KCI in water and then were fixed in methanol/ 
acetic acid, air dried on a microscope slide, and stained with Giemsa. 
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